Sickle Cell Anemia WE CARE

计划入组 112 人 · 首次发布于 2018 年 10 月 23 日

Isoquercetin in Sickle Cell Anemia

首次发布于 2020 年 7 月 17 日

Kidney Function in Sickle Cell Anemia

计划入组 300 人 · 首次发布于 2017 年 9 月 11 日

MBD inhibitors (cancer/sickle cell anemia)

orphan nuclear receptor modulator (sickle cell anemia)

Hydroxyurea(Droxia, Hydrea, Siklos, Xromi)

<dd class="col-xl-8 col-md-9 col-sm-8">CH₄N₂O₂</dd> · Rx

David Van Sickle

United States

Aplastic Anemia And Mds International Foundation Inc

United States

Gamida Cell

Israel

Allo-SCT Demonstrates Long-Term Superiority Over Standard Care in Sickle Cell Anemia

St. Louis Children's Hospital Begins Administering FDA-Approved Gene Therapy Lyfgenia for Sickle Cell Disease

Zydus Lifesciences Advances Desidustat into Phase III Sickle Cell Trial in Partnership with ICMR